Evidence map›Paper›PMID 36363152›Full record

ReviewMaterials (Basel, Switzerland)2022

Acridine and Its Derivatives: Synthesis, Biological, and Anticorrosion Properties.

Lipiar K M O Goni, Mohammad A Jafar Mazumder, Divya B Tripathy, Mumtaz A Quraishi

Open access · goldAbstract readReview
In one paragraph

Review in Materials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Experiments and Calculation on New N,N-Molecules (Basel, Switzerland) · 2024
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Lipiar K M O GoniChemistry Department, King Fahd University of Petroleum & Minerals, Dhahran 31261, Saudi Arabia.
Mohammad A Jafar MazumderChemistry Department, King Fahd University of Petroleum & Minerals, Dhahran 31261, Saudi Arabia.ORCID 0000-0002-2241-9596
Divya B TripathySchool of Basic and Applied Sciences, Galgotias University, Greater Noida 210310, India.
Mumtaz A QuraishiInterdisciplinary Research Center for Advanced Materials, King Fahd University of Petroleum & Minerals, Dhahran 31261, Saudi Arabia.
King Fahd University of Petroleum and Minerals · SAGalgotias University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The phenomenon of corrosion threatens metallic components, human safety, and the economy. Despite being eco-friendly and promising as a corrosion inhibitor, acridine has not been explored to its full potential. In this review, we have discussed multiple biological activities that acridines have been found to show in a bid to prove that they are environmentally benign and much less toxic than many inhibitors. Some synthetic routes to acridines and substituted acridines have also been discussed. Thereafter, a multitude of acridines and substituted acridines as corrosion inhibitors of different metals and alloys in various corrosive media have been highlighted. A short mechanistic insight into how acridine-based compounds function as corrosion inhibitors have also been included. We believe this review will generate an impression that there is still much to learn about previously reported acridines. In the wake of recent surges to find efficient and non-toxic corrosion inhibitors, acridines and their analogs could be an appropriate answer.

Indexed as

acridinesadsorptioncorrosioncorrosion inhibitorscorrosion protectionmetallic corrosion

Identifiers

PMID36363152
PMCPMC9658428
OpenAlexW4308118396

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.